Pathological non-response to chemotherapy in a neoadjuvant setting of breast cancer: an inter-institutional study
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Pathological non-response to chemotherapy in a neoadjuvant setting of breast cancer: an inter-institutional study
Authors
Keywords
Breast cancer, Neoadjuvant therapy, Non-response, Mitotic count, Proliferation
Journal
BREAST CANCER RESEARCH AND TREATMENT
Volume 148, Issue 3, Pages 511-523
Publisher
Springer Nature
Online
2014-11-14
DOI
10.1007/s10549-014-3192-3
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Tumor infiltrating lymphocytes are prognostic in triple negative breast cancer and predictive for trastuzumab benefit in early breast cancer: results from the FinHER trial
- (2014) S. Loi et al. ANNALS OF ONCOLOGY
- Response and prognosis after neoadjuvant chemotherapy in 1,051 patients with infiltrating lobular breast carcinoma
- (2014) Sibylle Loibl et al. BREAST CANCER RESEARCH AND TREATMENT
- Clinical significance of pretherapeutic Ki67 as a predictive parameter for response to neoadjuvant chemotherapy in breast cancer; is it equally useful across tumor subtypes?
- (2014) Aiko Sueta et al. SURGERY
- Ki67 levels as predictive and prognostic parameters in pretherapeutic breast cancer core biopsies: a translational investigation in the neoadjuvant GeparTrio trial
- (2013) C. Denkert et al. ANNALS OF ONCOLOGY
- Personalizing the treatment of women with early breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2013
- (2013) A. Goldhirsch et al. ANNALS OF ONCOLOGY
- Selecting the neoadjuvant treatment by molecular subtype: How to maximize the benefit?
- (2013) Gunter von Minckwitz et al. BREAST
- High Ki-67 score is indicative of a greater benefit from adjuvant chemotherapy when added to endocrine therapy in Luminal B HER2 negative and node-positive breast cancer
- (2013) Carmen Criscitiello et al. BREAST
- Response to neoadjuvant chemotherapy in ductal compared to lobular carcinoma of the breast: a meta-analysis of published trials including 1,764 lobular breast cancer
- (2013) Fausto Petrelli et al. BREAST CANCER RESEARCH AND TREATMENT
- Clinical benefit from neoadjuvant chemotherapy in oestrogen receptor-positive invasive ductal and lobular carcinomas
- (2013) Y Delpech et al. BRITISH JOURNAL OF CANCER
- CD4+ follicular helper T cell infiltration predicts breast cancer survival
- (2013) Chunyan Gu-Trantien et al. JOURNAL OF CLINICAL INVESTIGATION
- Prognostic and Predictive Value of Tumor-Infiltrating Lymphocytes in a Phase III Randomized Adjuvant Breast Cancer Trial in Node-Positive Breast Cancer Comparing the Addition of Docetaxel to Doxorubicin With Doxorubicin-Based Chemotherapy: BIG 02-98
- (2013) Sherene Loi et al. JOURNAL OF CLINICAL ONCOLOGY
- An International Ki67 Reproducibility Study
- (2013) Mei-Yin C. Polley et al. JNCI-Journal of the National Cancer Institute
- The Prognostic Value of Mitotic Activity Index (MAI), Phosphohistone H3 (PPH3), Cyclin B1, Cyclin A, and Ki67, Alone and in Combinations, in Node-Negative Premenopausal Breast Cancer
- (2013) Marie Klintman et al. PLoS One
- Tumor-infiltrating follicular helper T cells: The new kids on the block
- (2013) Chunyan Gu-Trantien et al. OncoImmunology
- Developments in Ki67 and other biomarkers for treatment decision making in breast cancer
- (2012) A. Sheri et al. ANNALS OF ONCOLOGY
- Immunohistochemical Ki67 labeling index has similar proliferation predictive power to various gene signatures in breast cancer
- (2012) Naoki Niikura et al. CANCER SCIENCE
- Adoption of Gene Expression Profile Testing and Association With Use of Chemotherapy Among Women With Breast Cancer
- (2012) Michael J. Hassett et al. JOURNAL OF CLINICAL ONCOLOGY
- Prognostic Significance of Progesterone Receptor–Positive Tumor Cells Within Immunohistochemically Defined Luminal A Breast Cancer
- (2012) Aleix Prat et al. JOURNAL OF CLINICAL ONCOLOGY
- Mitotic figure counts are significantly overestimated in resection specimens of invasive breast carcinomas
- (2012) Hans-Anton Lehr et al. MODERN PATHOLOGY
- Ki67, chemotherapy response, and prognosis in breast cancer patients receiving neoadjuvant treatment
- (2011) Peter A Fasching et al. BMC CANCER
- Ki-67: level of evidence and methodological considerations for its role in the clinical management of breast cancer: analytical and critical review
- (2011) Elisabeth Luporsi et al. BREAST CANCER RESEARCH AND TREATMENT
- Assessment of Ki67 in Breast Cancer: Recommendations from the International Ki67 in Breast Cancer Working Group
- (2011) M. Dowsett et al. JNCI-Journal of the National Cancer Institute
- The proliferation rate paradox in antimitotic chemotherapy
- (2011) Timothy J. Mitchison MOLECULAR BIOLOGY OF THE CELL
- In Patients Younger Than Age 55 Years With Lymph Node–Negative Breast Cancer, Proliferation by Mitotic Activity Index Is Prognostically Superior to Adjuvant!
- (2010) Tone Hoel Lende et al. JOURNAL OF CLINICAL ONCOLOGY
- The 70-gene signature as a response predictor for neoadjuvant chemotherapy in breast cancer
- (2009) Marieke E. Straver et al. BREAST CANCER RESEARCH AND TREATMENT
- Supervised Risk Predictor of Breast Cancer Based on Intrinsic Subtypes
- (2009) Joel S. Parker et al. JOURNAL OF CLINICAL ONCOLOGY
- Tumor-Associated Lymphocytes As an Independent Predictor of Response to Neoadjuvant Chemotherapy in Breast Cancer
- (2009) Carsten Denkert et al. JOURNAL OF CLINICAL ONCOLOGY
- Ki67 Index, HER2 Status, and Prognosis of Patients With Luminal B Breast Cancer
- (2009) Maggie C. U. Cheang et al. JNCI-Journal of the National Cancer Institute
- Prognostic and predictive value of the 21-gene recurrence score assay in postmenopausal women with node-positive, oestrogen-receptor-positive breast cancer on chemotherapy: a retrospective analysis of a randomised trial
- (2009) Kathy S Albain et al. LANCET ONCOLOGY
- Comparison of the prognostic significance of Chevallier and Sataloff's pathologic classifications after neoadjuvant chemotherapy of operable breast cancer
- (2008) Frederique Penault-Llorca et al. HUMAN PATHOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More